Literature DB >> 22463117

Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management.

Prachi Mehndiratta1, Sunil Manjila, Thomas Ostergard, Sylvia Eisele, Mark L Cohen, Cathy Sila, Warren R Selman.   

Abstract

Amyloid angiopathy-associated intracerebral hemorrhage (ICH) comprises 12%-15% of lobar ICH in the elderly. This growing population has an increasing incidence of thrombolysis-related hemorrhages, causing the management of hemorrhages associated with cerebral amyloid angiopathy (CAA) to take center stage. A concise reference assimilating the pathology and management of this clinical entity does not exist. Amyloid angiopathy-associated hemorrhages are most often solitary, but the natural history often progresses to include multifocal and recurrent hemorrhages. Compared with other causes of ICH, patients with CAA-associated hemorrhages have a lower mortality rate but an increased risk of recurrence. Unlike hypertensive arteriolar hemorrhages that occur in penetrating subcortical vessels, CAA-associated hemorrhages are superficial in location due to preferential involvement of vessels in the cerebral cortex and meninges. This feature makes CAA-associated hemorrhages easier to access surgically. In this paper, the authors discuss 3 postulates regarding the pathogenesis of amyloid hemorrhages, as well as the established clinicopathological classification of amyloid angiopathy and CAA-associated ICH. Common inheritance patterns of familial CAA with hemorrhagic strokes are discussed along with the role of genetic screening in relatives of patients with CAA. The radiological characteristics of CAA are described with specific attention to CAA-associated microhemorrhages. The detection of these microhemorrhages may have important clinical implications on the administration of anticoagulation and antiplatelet therapy in patients with probable CAA. Poor patient outcome in CAA-associated ICH is associated with dementia, increasing age, hematoma volume and location, initial Glasgow Coma Scale score, and intraventricular extension. The surgical management strategies for amyloid hemorrhages are discussed with a review of published surgical case series and their outcomes with a special attention to postoperative hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22463117     DOI: 10.3171/2012.1.FOCUS11370

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  29 in total

1.  The incidence of cerebral amyloid angiopathy in surgically treated intracranial hemorrhage in the Chinese population.

Authors:  Ya-juan Tang; Yong Li; Shuo Wang; Ming-wei Zhu; Yi-lin Sun; Ji-zong Zhao
Journal:  Neurosurg Rev       Date:  2013-06-14       Impact factor: 3.042

Review 2.  Small vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.

Authors:  Christian Schenk; Timothy Wuerz; Alan J Lerner
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

3.  The intracerebral hemorrhage blood transcriptome in humans differs from the ischemic stroke and vascular risk factor control blood transcriptomes.

Authors:  Boryana Stamova; Bradley P Ander; Glen Jickling; Farah Hamade; Marc Durocher; Xinhua Zhan; Da Zhi Liu; Xiyuan Cheng; Heather Hull; Alan Yee; Kwan Ng; Natasha Shroff; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-13       Impact factor: 6.200

4.  Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement.

Authors:  Shinsuke Nishimura; Tomoji Matsumae; Yuji Murakami; Yasuhiro Abe; Yoshie Sasatomi; Ikufumi Nagayoshi; Kazuo Ueda; Hitoshi Nakashima
Journal:  CEN Case Rep       Date:  2014-04-16

Review 5.  Injury mechanisms in acute intracerebral hemorrhage.

Authors:  D Andrew Wilkinson; Aditya S Pandey; B Gregory Thompson; Richard F Keep; Ya Hua; Guohua Xi
Journal:  Neuropharmacology       Date:  2017-09-22       Impact factor: 5.250

6.  Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy.

Authors:  Octavio M Pontes-Neto; Eitan Auriel; Steven M Greenberg
Journal:  Eur Neurol Rev       Date:  2012

7.  Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys).

Authors:  Olivia M D'Angelo; Jeromy Dooyema; Cynthia Courtney; Lary C Walker; Eric Heuer
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

Review 8.  Challenges for intraventricular hemorrhage research and emerging therapeutic targets.

Authors:  Thomas Garton; Ya Hua; Jianming Xiang; Guohua Xi; Richard F Keep
Journal:  Expert Opin Ther Targets       Date:  2017-10-30       Impact factor: 6.902

9.  Brain Injury Lesion Imaging Using Preconditioned Quantitative Susceptibility Mapping without Skull Stripping.

Authors:  S Soman; Z Liu; G Kim; U Nemec; S J Holdsworth; K Main; B Lee; S Kolakowsky-Hayner; M Selim; A J Furst; P Massaband; J Yesavage; M M Adamson; P Spincemaille; M Moseley; Y Wang
Journal:  AJNR Am J Neuroradiol       Date:  2018-02-22       Impact factor: 3.825

Review 10.  Diagnosis and Treatment of Primary Central Nervous System Angiitis.

Authors:  Kaustubh Limaye; Edgar A Samaniego; Harold P Adams
Journal:  Curr Treat Options Neurol       Date:  2018-08-04       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.